Evidence map›Paper›PMID 30998701›Full record

Trial reportPloS one2019

Unusual prevalence of high-risk genotypes of human papillomavirus in a group of women with neoplastic lesions and cervical cancer from Central Mexico.

Rafael Gutiérrez Campos, Angélica Malacara Rosas, Elvia Gutiérrez Santillán, Mireya Delgado Gutiérrez, Rusland Enrique Torres Orozco, Elí Daniel García Martínez, Luis Fernando Torres Bernal, Alejandro Rosas Cabral

Open access · goldAbstract readClinical Trial
In one paragraph

Trial report in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Rafael Gutiérrez CamposDepartment of Chemistry, Center for Basic Sciences, Autonomous University of Aguascalientes, Aguascalientes, Aguascalientes, México.ORCID 0000-0002-6268-209X
Angélica Malacara RosasDepartment of Chemistry, Center for Basic Sciences, Autonomous University of Aguascalientes, Aguascalientes, Aguascalientes, México.
Elvia Gutiérrez SantillánHospital General de Zona Número 6, Instituto Mexicano del Seguro Social, Monterrey, Nuevo León, México.
Mireya Delgado GutiérrezHospital General de Zona Número 1, Instituto Mexicano del Seguro Social, Aguascalientes, Aguascalientes, México.
Rusland Enrique Torres OrozcoDepartment of Chemistry, Center for Basic Sciences, Autonomous University of Aguascalientes, Aguascalientes, Aguascalientes, México.
Elí Daniel García MartínezDepartment of Chemistry, Center for Basic Sciences, Autonomous University of Aguascalientes, Aguascalientes, Aguascalientes, México.
Luis Fernando Torres BernalDepartment of Medicine, Center for Health Sciences, Autonomous University of Aguascalientes, Aguascalientes, México.
Alejandro Rosas CabralDepartment of Medicine, Center for Health Sciences, Autonomous University of Aguascalientes, Aguascalientes, México.
Autonomous University of Aguascalientes · MXMexican Social Security Institute · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human papillomavirus has been identified as a main etiological agent in the development of cervical cancer. HPV 16 and 18 have been reported the most widely prevalent genotypes worldwide. We conducted a study analyzing the prevalence of high and low risk human papillomavirus viral types in the Mexican state of Aguascalientes and neighboring cities in the states of Jalisco and Zacatecas in central Mexico. Specific viral genotype was determined by a PCR and hybridization-based detection test. The presence of 37 high- and low-risk HPV genotypes was evaluated in 883 female participants. Of these, 350 presented low-grade squamous intraepithelial lesions (LGSIL), 176 presented high-grade squamous intraepithelial lesions (HGSIL), 107 suffered from cervical cancer and 250 women with negative cytological report for intraepithelial lesion or malignancy (NILM). HPV 51 was the most prevalent genotype, followed by HPV 16: overall prevalence of HPV 51, including single infections and co-infections was 31.2% in women with LGSIL, whereas prevalence of HPV 16 was 25.1%. Among women with HGSIL, HPV 51 prevalence was 47.2% and HPV 16 was 30.1%. Prevalence of HPV 51 in women with cervical cancer was 49.5% and type 16 was 33.6%. Between single and co-infections, most co-infections were not associated with later stages of the disease, except 51/16 and some others. HPV 51 showed a significant correlation with the progression of the disease (OR = 10.81 for LGSIL, 19.38 for HGSIL and 22.95 for ICC), and when analyzing all other genotypes, five different groups depending on their correlation with all lesion grades were determined. According to our findings, HPV genotype 51 has a higher prevalence than HPV 16 and 18 in the Mexican state of Aguascalientes and neighboring cities in the states of Jalisco and Zacatecas in Central Mexico.

Indexed as

GenotypePapillomavirus InfectionsUterine Cervical NeoplasmsAdolescentAdultAgedFemaleHumansMexicoMiddle AgedPapillomaviridaePrevalenceRetrospective Studies

Identifiers

PMID30998701
PMCPMC6474327
OpenAlexW2938843876

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.